Impact of body mass index on peripheral and uterine immune status in the window of implantation in patients with recurrent reproductive failure

Hum Fertil (Camb). 2023 Dec;26(5):1322-1333. doi: 10.1080/14647273.2023.2189024. Epub 2023 Mar 22.

Abstract

This study aimed to investigate whether maternal obesity affects the immune status of peripheral blood and endometrium in patients with recurrent reproductive failure classified according to their body mass index (BMI). A total of 228 repeated implantation failure (RIF) and 266 recurrent miscarriage (RM) patients were enrolled in the study and further subdivided into three groups according to their BMI: (i) normal weight (18.5≤ BMI <23); (ii) overweight (23≤ BMI <25); and (iii) obese (BMI ≥25). Peripheral blood and endometrium samples were collected in the mid-luteal phase before IVF treatment or natural pregnancy. Peripheral immunocytes were analyzed by flow cytometry, while uterine immune cells were subjected to immunohistochemistry. In RM patients, significantly increased peripheral helper T cells and decreased cytotoxic T cells, NK cells were observed in the obese group compared with the normal-weight group. Meanwhile, in the endometrium, the percentage of NK cell, macrophage cell, M2 macrophage cell, and Treg cell significantly reduced with increased BMI in RIF patients, and the percentage of NK cell and M2 macrophage cell significantly decreased with increased BMI in RM patients. In conclusion, obesity may cause endometrial immune disorder in recurrent reproductive failure women, but was only associated with the peripheral immune change in RM patients.

Keywords: Obesity; immune state; recurrent miscarriage; repeated implantation failure.

MeSH terms

  • Abortion, Habitual*
  • Body Mass Index
  • Embryo Implantation*
  • Endometrium
  • Female
  • Humans
  • Obesity / complications
  • Pregnancy